Loading
Latest filing published 12 Feb 2026 for Avadel Pharmaceuticals PLC, €1.8M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Thomas S. Mchugh (finance chief) discloses dealings in Avadel Pharmaceuticals PLC to SEC (Form 4). Between 27 May 2022 and 12 February 2026, the trades on record add up to 8 filings.
On the market, this insider has only ever bought: 6 purchases, €263k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant.
In size, the median ticket on the buying side is €32k. 5 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 12 February 2026 with a transaction (€1.8M) in Avadel Pharmaceuticals PLC. The last purchase on record was published on 16 December 2024, which is 671 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations